A 42-year-old woman with liver masses and long-term use of oral contraceptives

Seminars in Liver Disease

Volumn 19, Issue 3, 1999, Pages 339-344

  Ye, Ming Q ^a,b   Suriawinata, Arief ^a   Haim, Menahem Ben ^a   Parsons, Rosaleen ^a   Schwartz, Myron E ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORGESTIMATE; LEVONORGESTREL; MESTRANOL; MESTRANOL PLUS NORETHISTERONE; NORETHISTERONE; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER TUMOR; LONG TERM CARE; ORAL CONTRACEPTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032830517     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007123     Document Type: Article

References (22)

1. Mergo PJ, Ros PR. Benign lesions of the liver. Radiol Clin North Am 1998;36:319-331
2. Fernandez MP, Redvanly RD. Primary hepatic malignant neoplasm. Radiol Clin North Am 1998;36:333-349
3. Palmer JR, Rosenberg L, Kaufman DW, et al. Oral contraceptive use and liver cancer. Am J Epidemiol 1989;130:878-882
4. Lees T, Farges O, Bismus H. Liver cell adenomas - a 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988;208:558-564
5. Ferrell L. Malignant liver tumors that mimic benign lesions: Analysis of five distinct lesions. Semin Diagn Pathol 1995;12: 64-76
6. Baum JK, Holtz F, Bookstein JJ. Possible association between benign hepatomas and oral contraceptives. Lancet 1973;2:926-929
7. Edmondson HA, Henderson BE, Benton B. Liver cell adenomas associated with the use of oral contraceptives. N Engl J Med 1976;294:470-472
8. Rooks JB, Dry HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. J Am Med Assoc 1979;242:644-648
9. Tesluk H, Lawrie J. Hepatocellular adenoma - Its transformation to carcinoma in a user of oral contraceptives. Arch Pathol Lab Med 1981;105:296-299
10. Neuberger J, Forman D, Doll R, Williams R. Oral contraceptives and hepatocellular carcinoma. Br Med J 1986;292:1355-1357
11. Forman D, Vincent TJ, Doll R. Cancer of the liver and the use of oral contraceptives. Br Med J 1986;292:1357-1361
12. Henderson BE, Preston-Martin S, Edmondson HA, Peters RL, Pike MC. Hepatocellular carcinoma and oral contraceptives. Br J Cancer 1983;48:437-440
13. Thung SN, Gerber MA. Development of malignancy in benign tumors of the liver. In: Tabor E, Di Bisceglie AM, Purcell RH (eds). Etiology, Pathology and Treatment of Hepatocellular Carcinoma in North America. Houston: Gulf Publishing, 1991: 209-215
14. Gordon SC, Reddy R, Livingstone AS, Jeffers LJ, Schiff ER. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Intern Med 1986;105:547-549
15. Gyorffy EJ, Bredfeldt JE, Black WC. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Ann Intern Med 1989;110:489-490
16. Korula J, Yellin A, Kanel G, Camporiofi G, Nichols P. Hepatocellular carcinoma coexisting with hepatic adenoma - Incidental discovery after long-term oral contraceptive use. West J Med 1991;155:416-418
17. Ferrell LD. Hepatocellular carcinoma arising in a focus of multi-lobular adenoma - A case report. Am J Surg Pathol 1993;17: 525-529
18. Fiel MI, Min A, Gerber MA, et al. Hepatocellular carcinoma in long-term oral contraceptive use. Liver 1996;16:372-376
19. Tao L-C. Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cancer 1991;68:341-347
20. Edmondson HA, Reynolds TB, Henderson B, Benton B. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 1977;86:180-182
21. Marks W, Thompson, N, Appleman H. Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. Ann Surg 1988;208:190-195
22. Roth JA, Befeler D, Berman E, Johnson FB. A black hepatocellular carcinoma with Dubin-Johnson-like pigment and Mallory bodies. Am J Surg Pathol 1982;6: 375-382